Skip to content

Timing of Target Enteral Feeding in the Mechanically Ventilated Patient

Phase III Study of Early vs. Delayed Goal Enteral Nutrition in Mechanically Ventilated Patients

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00252616
Enrollment
200
Registered
2005-11-11
Start date
2003-09-30
Completion date
2009-10-31
Last updated
2013-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Failure

Keywords

Mechanical ventilation, acute respiratory failure, early nutrition

Brief summary

This study tests the hypothesis that initial trophic enteral feedings will increase the time alive and free of mechanical ventilation as compared to initial goal enteral feedings in patients who are mechanically ventilated.

Detailed description

Mechanically ventilated patients, within 48 hours of initiating mechanical ventilation, are randomized in a 1:1 fashion to receive trophic enteral feedings for 96 hours followed by advancement to goal feeding rates or initial advancement to goal feeding rates. Primary endpoints are ventilator free days, ICU-free days, gastrointestinal intolerances, development of nosocomial infections, and mortality.

Interventions

BEHAVIORALtrophic enteral feeds

10cc/hr

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
Vanderbilt University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
13 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients will be eligible for inclusion in the study if they meet the following criteria: * Mechanical ventilation expected to last at least 72 hours. * Presence of, or primary physician's intent to place, an enteral feeding tube and begin enteral feeds.

Exclusion criteria

* More than 48 hours elapsed since both inclusion criteria met. * Patient, legal representative, or physician refuses consent or is unavailable to provide consent. * Patient, legal representative, or physician not committed to full support (Exception: A patient will not be excluded if he/she would receive all supportive care except for attempts at resuscitation from cardiac arrest). * Presence of malignant or irreversible condition and estimated 28 day mortality greater than 50%. * Severe or refractory shock. * Moribund patients not expected to survive 24 hours from start of enteral feeding (as determined by primary medical team). * Child-Pugh score greater than 10. * Presence of partial or complete mechanical bowel obstruction, or ischemia, or infarction. * Current TPN use or intent to use TPN within 7 days. * Severe malnutrition with BMI less than 18.5 and/or loss of more than 30% total body weight in the previous 6 months. * Neuromuscular disease impairing the ability to ventilate spontaneously. * Laparotomy expected within 7 days. * Unable to raise head of bed 45°. * greater than 30% total body surface area burns. * Absence of GI tract/short bowel syndrome - defined as entire length of small bowel totaling 4 feet or less. * Presence of high-output (\> 500 cc/day) enterocutaneous fistula. * Age less than 13 years * Allergy to enteral formula

Design outcomes

Primary

MeasureTime frame
Ventilator-free daysday 28

Secondary

MeasureTime frame
Mortality28 days
Incidence of Gastrointestinal intolerancesday 14
ICU-free daysday 28
Changes in inflammation as measured by serum cytokine levelsbaseline vs. days 6 and 12
Changes in levels of nutrition as measured by serum albumin, total protein, and pre-albuminbaseline vs. days 6 or 12
Organ failure-free daysday 28

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026